Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Unilever
UL
$141B
| $44.7M | 0.01% |
879,023
+114,630
| +15% | +$5.58M |
|
|
LTXB
1152
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $44.6M | 0.01% |
2,270,935
-55,279
| -2% | -$1.08M |
|
1153
iShares US Transportation ETF
IYT
$2.26B
| $44.5M | 0.01% |
1,250,740
-1,359,596
| -52% | -$44.4M |
|
1154
Semtech
SMTC
$10.7B
| $44.5M | 0.01% |
2,024,380
-33,245
| -2% | -$640K |
|
1155
Kohl's
KSS
$2.21B
| $44.5M | 0.01% |
954,806
-314,204
| -25% | -$14.7M |
|
1156
First Financial Bankshares
FFIN
$5B
| $44.4M | 0.01% |
3,005,222
-68,680
| -2% | -$943K |
|
1157
Prestige Consumer Healthcare
PBH
$2.37B
| $44.4M | 0.01% |
832,505
-42,964
| -5% | -$2.12M |
|
1158
RBC Bearings
RBC
$17.8B
| $44.4M | 0.01% |
605,407
+27,632
| +5% | +$1.75M |
|
1159
Plexus
PLXS
$6.47B
| $44.3M | 0.01% |
1,121,440
+3,292
| +0.3% | +$117K |
|
1160
UDR
UDR
$12.3B
| $44.3M | 0.01% |
1,148,900
+82,916
| +8% | +$2.97M |
|
|
VMW
1161
DELISTED
VMware, Inc
VMW
| $44.3M | 0.01% |
846,222
-1,786,750
| -68% | -$88.5M |
|
|
ALR
1162
DELISTED
Alere Inc
ALR
| $44.2M | 0.01% |
872,866
+701,637
| +410% | +$33.6M |
|
|
P
1163
DELISTED
Pandora Media Inc
P
| $44.2M | 0.01% |
4,934,059
+816,029
| +20% | +$8.01M |
|
1164
CALL
Regeneron Pharmaceuticals
REGN
$77.4B
| $44.2M | 0.01% |
122,500
+56,900
| +87% | +$23.4M |
|
|
FCS
1165
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $44.1M | 0.01% |
2,207,394
+32,183
| +1% | +$652K |
|
|
YHOO
1166
CALL
DELISTED
Yahoo Inc
YHOO
| $44.1M | 0.01% |
1,197,500
-1,305,300
| -52% | -$40.9M |
|
1167
TD Synnex
SNX
$20.2B
| $44.1M | 0.01% |
951,674
+597,648
| +169% | +$26.7M |
|
1168
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $43.7M | 0.01% |
1,442,608
-286,724
| -17% | -$8.11M |
|
1169
TAL Education Group
TAL
$6.85B
| $43.6M | 0.01% |
5,261,250
-37,044
| -0.7% | -$296K |
|
1170
Community Bank
CBU
$3.42B
| $43.5M | 0.01% |
1,138,947
-13,040
| -1% | -$487K |
|
1171
Eastman Chemical
EMN
$8.01B
| $43.5M | 0.01% |
601,963
+32,161
| +6% | +$2.11M |
|
1172
West Pharmaceutical
WST
$23.9B
| $43.4M | 0.01% |
626,014
+342,331
| +121% | +$20.6M |
|
1173
Aptiv
APTV
$12.3B
| $43.3M | 0.01% |
577,409
-435,712
| -43% | -$29.8M |
|
1174
Robert Half
RHI
$3.81B
| $43.2M | 0.01% |
927,886
-94,862
| -9% | -$3.97M |
|
|
NVO
1175
Novo Nordisk
NVO
$228B
| $43.2M | 0.01% |
1,594,630
+152,782
| +11% | +$4.09M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.